Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

FHS
October 2, 2023
10:49 am

EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.

BMS secures another EC approval for Opdivo combination – Pharmaceutical Technology

BMS received European approval for its Opdivo combination therapy as a first-line treatment for adult patients with unresectable or metastatic urothelial carcinoma. Credit: HJBC via

May 29, 2024

Tracking the FDA advisory panel on MDMA therapy for PTSD

Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for

June 4, 2024

Lilly’s weekly insulin hits primary endpoints in two more late-stage diabetes studies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.